Abpro Holdings (ABPO) Change in Cash (2022 - 2026)
Abpro Holdings' (ABPO) quarterly Change in Cash came in at $5.3 million in Q1 2026, up 435.92% YoY from $994743.9 in Q1 2025, and up 2142.53% on a QoQ basis from -$261000.0 in Q4 2025.
Abpro Holdings (ABPO) Change in Cash (2022 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 5 years of Change in Cash data on file, last reported at $5.3 million in Q1 2026.
- Quarterly Change in Cash rose 435.92% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 282.81% YoY) and the FY2025 annual result came in at -$2.9 million, down 236.56% from the prior year.
- Change in Cash rose to $5.3 million in Q1 2026, from -$261000.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $5.3 million in Q1 2026 to a low of -$7.2 million in Q4 2023.
- A 5-year average of -$97444.4 and a median of -$97222.0 in 2023 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 5537.35% in 2023, down 3618.28% in 2023.
- Tracing ABPO's Change in Cash over 5 years: stood at $203415.0 in 2022, then slumped by 3618.28% to -$7.2 million in 2023, then soared by 139.84% to $2.9 million in 2024, then slumped by 109.15% to -$261000.0 in 2025, then soared by 2142.53% to $5.3 million in 2026.
- The last three Change in Cash figures came in at $5.3 million (Q1 2026), -$261000.0 (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | -1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.33 Mn |
| Dec 31, 2025 | -261,000.00 |
| Sep 30, 2025 | -1.69 Mn |
| Jun 30, 2025 | 624,000.00 |
| Mar 31, 2025 | -1.59 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Sep 30, 2024 | -61,000.00 |
| Jun 30, 2024 | -156,000.00 |
| Mar 31, 2024 | -503,000.00 |
| Dec 31, 2023 | -7.16 Mn |
| Sep 30, 2023 | -1.28 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | -97,222.00 |
| Dec 31, 2022 | 203,415.00 |
| Sep 30, 2022 | -105,997.00 |
| Jun 30, 2022 | -35,541.00 |
| Mar 31, 2022 | 330,569.00 |